Review



cd86 pe 65068  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Proteintech cd86 pe 65068
    Cd86 Pe 65068, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 40 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86 pe 65068/product/Proteintech
    Average 93 stars, based on 40 article reviews
    cd86 pe 65068 - by Bioz Stars, 2026-02
    93/100 stars

    Images



    Similar Products

    94
    Multi Sciences (Lianke) Biotech Co Ltd pe anti mouse cd86
    Pe Anti Mouse Cd86, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pe anti mouse cd86/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 94 stars, based on 1 article reviews
    pe anti mouse cd86 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec cd86 pe
    Cd86 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86 pe/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    cd86 pe - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Proteintech cd86 pe 65068
    Cd86 Pe 65068, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86 pe 65068/product/Proteintech
    Average 93 stars, based on 1 article reviews
    cd86 pe 65068 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech cd86
    Cd86, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86/product/Proteintech
    Average 93 stars, based on 1 article reviews
    cd86 - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    cd86  (Bioss)
    94
    Bioss cd86
    Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of <t>CD86</t> and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.
    Cd86, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd86/product/Bioss
    Average 94 stars, based on 1 article reviews
    cd86 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    93
    Proteintech anti mouse cd86 pe
    Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of <t>CD86</t> and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.
    Anti Mouse Cd86 Pe, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse cd86 pe/product/Proteintech
    Average 93 stars, based on 1 article reviews
    anti mouse cd86 pe - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Cytek Biosciences 0862 u025 anti mouse cd25 brilliant violet
    Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of <t>CD86</t> and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.
    0862 U025 Anti Mouse Cd25 Brilliant Violet, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/0862 u025 anti mouse cd25 brilliant violet/product/Cytek Biosciences
    Average 93 stars, based on 1 article reviews
    0862 u025 anti mouse cd25 brilliant violet - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher anti-mouse cd86-pe
    Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of <t>CD86</t> and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.
    Anti Mouse Cd86 Pe, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-mouse cd86-pe/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    anti-mouse cd86-pe - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Multi Sciences (Lianke) Biotech Co Ltd anti mouse cd86 pe
    Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of <t>CD86</t> and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.
    Anti Mouse Cd86 Pe, supplied by Multi Sciences (Lianke) Biotech Co Ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse cd86 pe/product/Multi Sciences (Lianke) Biotech Co Ltd
    Average 94 stars, based on 1 article reviews
    anti mouse cd86 pe - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    Image Search Results


    Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of CD86 and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.

    Journal: Advanced Science

    Article Title: Synergistic Modulation of Microglial Polarization by Acteoside and Ferulic Acid via Dual Targeting of Nrf2 and RORγt to Alleviate Depression‐Associated Neuroinflammation

    doi: 10.1002/advs.202503889

    Figure Lengend Snippet: Cooperative effects of ACT and FA on microglial polarization in the LPS‐induced BV2 cells. The effects of FA A) and ACT B) on BV2 cells viability. Effects of FA or ACT single treatments on the levels of IL‐6, IL‐17A C), IL‐1β, and IL‐10 D). E) Neuroprotection of ACT synergistic FA on LPS‐induced BV2 cell morphology (100 µm). F) Statistical analysis of co‐treatment of ACT synergistic FA replicated the equivalent ratio of them in the BDD on the M1 and M2 polarization markers of microglia‐associated mRNAs expression. G) Expression level of the IL‐6, IL‐17A, IL‐1β, and IL‐10 in the supernatant of BV2 cells. H) Flow cytometry of CD86 and CD206 in the LPS‐induced BV2 cells. Quantitative analysis of Nrf2, TREM2, and DAP12 mRNAs I) and proteins J) expression level. GAPDH was set as the internal control. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01 and *** p <0.001, compared with the control group; # p <0.05, ## p <0.01 and ### p <0.001, compared with the LPS‐induced cell model group; & P <0.05, && P <0.01 and &&& P <0.001, compared with the ACT+FA treatment group.

    Article Snippet: For microglial polarization phenotype analysis, BV‐2 cells were harvested 24 h after treatment, washed sequentially in ice‐cold flow buffer, and incubated with specific antibodies against CD206 (bsm‐30276A‐FITC; Bioss) and CD86 (bsm‐30162A‐PE; Bioss).

    Techniques: Expressing, Flow Cytometry, Control

    siRNA knockdown of Nrf2 reverses the phenotypic transformation induced by ACT and FA in BV2 cells. A) Schematic diagram of plasmid transfection efficiency with GFP fluorescence in different time points (1/8/16/24 h), and qRT‐PCR was used to detect the knockdown efficiency of siRNA targeted Nrf2. B) The expression levels of IL‐1β, IL‐6, IL‐17A, and IL‐10 in BV2 cells were tested by ELISA. C)The levels of polarization biomarkers of CD86 and CD206 were detected by flow cytograms of BV2 cells in each group. D) Relative mRNA expression levels of M1 and M2 markers, and Nrf2/TREM2/DAP12 in the different groups. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01, and *** p <0.001, compared with the Si‐NC group; # p <0.05, ## p <0.01, and ### p <0.001, compared with the LPS‐induced cell model treated by ACT and FA.

    Journal: Advanced Science

    Article Title: Synergistic Modulation of Microglial Polarization by Acteoside and Ferulic Acid via Dual Targeting of Nrf2 and RORγt to Alleviate Depression‐Associated Neuroinflammation

    doi: 10.1002/advs.202503889

    Figure Lengend Snippet: siRNA knockdown of Nrf2 reverses the phenotypic transformation induced by ACT and FA in BV2 cells. A) Schematic diagram of plasmid transfection efficiency with GFP fluorescence in different time points (1/8/16/24 h), and qRT‐PCR was used to detect the knockdown efficiency of siRNA targeted Nrf2. B) The expression levels of IL‐1β, IL‐6, IL‐17A, and IL‐10 in BV2 cells were tested by ELISA. C)The levels of polarization biomarkers of CD86 and CD206 were detected by flow cytograms of BV2 cells in each group. D) Relative mRNA expression levels of M1 and M2 markers, and Nrf2/TREM2/DAP12 in the different groups. Results are presented as the mean ± SEM of three independent experiments. * p <0.05, ** p <0.01, and *** p <0.001, compared with the Si‐NC group; # p <0.05, ## p <0.01, and ### p <0.001, compared with the LPS‐induced cell model treated by ACT and FA.

    Article Snippet: For microglial polarization phenotype analysis, BV‐2 cells were harvested 24 h after treatment, washed sequentially in ice‐cold flow buffer, and incubated with specific antibodies against CD206 (bsm‐30276A‐FITC; Bioss) and CD86 (bsm‐30162A‐PE; Bioss).

    Techniques: Knockdown, Transformation Assay, Plasmid Preparation, Transfection, Fluorescence, Quantitative RT-PCR, Expressing, Enzyme-linked Immunosorbent Assay